These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Adult Hodgkin lymphoma AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
29 results:

  • 1. Tumorous formation of the forehead.
    Temelkova I; Tchernev G
    Wien Med Wochenschr; 2020 May; 170(7-8):196-198. PubMed ID: 31993874
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.
    Maes A; Maes K; Vlummens P; De Raeve H; Devin J; Szablewski V; De Veirman K; Menu E; Moreaux J; Vanderkerken K; De Bruyne E
    Blood Cancer J; 2019 Nov; 9(12):87. PubMed ID: 31740676
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis.
    Liu PP; Wang KF; Jin JT; Bi XW; Sun P; Wang Y; Yang H; Li ZM; Jiang WQ; Xia Y
    Cancer Med; 2018 May; 7(5):1845-1851. PubMed ID: 29624913
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immunotherapy with the trifunctional anti-cd20 x anti-CD3 antibody FBTA05 (Lymphomun) in paediatric high-risk patients with recurrent cd20-positive B cell malignancies.
    Schuster FR; Stanglmaier M; Woessmann W; Winkler B; Siepermann M; Meisel R; Schlegel PG; Hess J; Lindhofer H; Borkhardt A; Buhmann R
    Br J Haematol; 2015 Apr; 169(1):90-102. PubMed ID: 25495919
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Chlorambucil-rituximab as first-line therapy in patients affected by follicular non-hodgkin's lymphoma: a retrospective single-centre study.
    Martinelli G; Montoro J; Vanazzi A; Andreola G; Liptrott S; Radice D; Negri M; Preda L; Pruneri G; Laszlo D
    Hematol Oncol; 2015 Dec; 33(4):129-35. PubMed ID: 25047267
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky hodgkin lymphoma.
    Hartridge-Lambert SK; Schöder H; Lim RC; Maragulia JC; Portlock CS
    Cancer; 2013 Mar; 119(6):1203-9. PubMed ID: 23132361
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Interstitial pneumonitis during rituximab-containing chemotherapy for non-hodgkin lymphoma.
    Liu X; Hong XN; Gu YJ; Wang BY; Luo ZG; Cao J
    Leuk Lymphoma; 2008 Sep; 49(9):1778-83. PubMed ID: 18798110
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. FcgammaRIIa polymorphism and clinical response to rituximab in non-hodgkin lymphoma patients.
    Paiva M; Marques H; Martins A; Ferreira P; Catarino R; Medeiros R
    Cancer Genet Cytogenet; 2008 May; 183(1):35-40. PubMed ID: 18474295
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases.
    Wöhrer S; Troch M; Zwerina J; Schett G; Skrabs C; Gaiger A; Jaeger U; Zielinski CC; Raderer M
    Ann Oncol; 2007 Apr; 18(4):647-51. PubMed ID: 17218490
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical hodgkin's lymphoma: a clinicopathologic study.
    Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
    J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma involving the breast. A report of four cases.
    Pisani F; Romano A; Anticoli Borza P; Marino M; Micheli A; Botti C; Petti MC
    J Exp Clin Cancer Res; 2006 Jun; 25(2):277-81. PubMed ID: 16918141
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.
    Pitman SD; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Berdeja JG; Weiss LM; Wang J
    Am J Surg Pathol; 2006 Apr; 30(4):470-6. PubMed ID: 16625093
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immunophenotypic changes and clinical outcome in B-cell lymphomas treated with rituximab.
    Seliem RM; Freeman JK; Steingart RH; Hasserjian RP
    Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):18-23. PubMed ID: 16540725
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. cFLIP expression correlates with tumour progression and patient outcome in non-hodgkin lymphomas of low grade of malignancy.
    Valente G; Manfroi F; Peracchio C; Nicotra G; Castino R; Nicosia G; Kerim S; Isidoro C
    Br J Haematol; 2006 Mar; 132(5):560-70. PubMed ID: 16445828
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides.
    Jahrsdorfer B; Mühlenhoff L; Blackwell SE; Wagner M; Poeck H; Hartmann E; Jox R; Giese T; Emmerich B; Endres S; Weiner GJ; Hartmann G
    Clin Cancer Res; 2005 Feb; 11(4):1490-9. PubMed ID: 15746051
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Monoclonal antibody therapy and laboratory medicine].
    Takeshita A
    Rinsho Byori; 2004 Nov; 52(11):917-23. PubMed ID: 15658471
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis.
    Kremer M; Ott G; Nathrath M; Specht K; Stecker K; Alexiou C; Quintanilla-Martinez L; Fend F
    J Pathol; 2005 Jan; 205(1):92-101. PubMed ID: 15586381
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. AIDS-related cancer in the era of highly active antiretroviral therapy (HAART): a model of the interplay of the immune system, virus, and cancer. "On the offensive--the Trojan Horse is being destroyed"--Part B: Malignant lymphoma.
    Cheung TW
    Cancer Invest; 2004; 22(5):787-98. PubMed ID: 15581059
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Adverse prognostic significance of cd20 positive Reed-Sternberg cells in classical hodgkin's disease.
    Portlock CS; Donnelly GB; Qin J; Straus D; Yahalom J; Zelenetz A; Noy A; O'Connor O; Horwitz S; Moskowitz C; Filippa DA
    Br J Haematol; 2004 Jun; 125(6):701-8. PubMed ID: 15180859
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Ex vivo B cell depletion using the Eligix B Cell SC system and autologous peripheral blood stem cell transplantation in patients with follicular non-hodgkin's lymphoma.
    Friedberg JW; Kim H; Li S; Neuberg D; Boyd K; Daley H; Fisher DC; Gribben JG; Spitzer T; Freedman AS
    Bone Marrow Transplant; 2003 Oct; 32(7):681-6. PubMed ID: 13130315
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.